Skip to content

4Accepted Sep 16, 5:57 PM ET

Alignment Healthcare (ALHC) CEO John Kao Sells 27,400 Shares

ALHCAlignment Healthcare, Inc.

Accepted (ET)

5:57 PM

Sep 16, 2026

Filed

Sep 16, 2026

Documents

1

Size

5.6 KB

Summary

Alignment Healthcare (ALHC) CEO John Kao Sells 27,400 Shares

Updated

What Happened
John E. Kao, CEO of Alignment Healthcare (ALHC), sold 27,400 shares in an open-market transaction on September 14, 2026, at $13.00 per share, generating proceeds of $356,200. The sale is reported on a Form 4 filed with the SEC on September 16, 2026.

Key Details

  • Transaction date and price: 2026-09-14, sale at $13.00 per share.
  • Shares sold / value: 27,400 shares; proceeds $356,200.
  • Shares owned after transaction: Not specified in this filing; the reported securities were held by the JEK Trust (see footnote).
  • Footnotes: F1 — sale may be under a Rule 10b5-1 plan adopted 05/27/2026; F2 — securities represented are held by the JEK Trust dated Feb 8, 2021, of which Mr. Kao is trustee.
  • Timeliness: Form 4 filed on 2026-09-16 (two business days after the transaction), indicating a timely filing.

Context
This was a sale (transaction code S). Sales by insiders can be routine (including planned dispositions under 10b5-1 plans) and do not alone indicate a change in company fundamentals. The presence of a 10b5-1 plan note suggests the trade may have been prearranged.

AI-written summary · check the filing